COMPARISON OF SAFETY AND EFICACY OF ROSUVASTATIN (10 MG) AND ATORVASTATIN (30MG) IN CASES OF DYSLIPIDEMIA OVER TWELVE WEEKS OF TREATMENT - Current Issue - IJAR